Pelotonia Research Center
2255 Kenny Rd
Room 4121
Columbus, OH 43210
Liujiang.Song@osumc.edu
Dr. Song is a research faculty member with a joint appointment in the Department of Ophthalmology & Vision Sciences and Biological Chemistry & Pharmacology, based at the Gene Therapy Institute. Her research focuses on parvoviruses, particularly Adeno-associated virus (AAV) biology, vector engineering, and the development of AAV-based gene therapies.
Dr. Song is working in close collaboration with Ophthalmology colleagues to develop gene therapy solutions for ocular diseases that cause vision loss, with a particular emphasis on corneal diseases—while also extending applications to other disease areas.
Research Interests
- Adeno-associated virus
- Gene therapy
- Anterior segment ocular diseases
Publications
Education and Training
Bachelor of Clinical Medicine: Hunan University of Chinese Medicine, Hunan, China
PhD: A joint Ph.D. program at the University of Florida and Xiangya Medical School at the Central South University, China
Post-Doctoral Fellowship: Department of Pathology, University of Utah
Post-Doctoral Fellowship: Gene Therapy Center & Department of Ophthalmology, University of North Carolina
Society Memberships
- American Society of Gene & Cell Therapy (ASGCT), 2010-present
- The Association for Research in Vision and Ophthalmology (ARVO), 2019-present
- European Society of Gene & Cell Therapy (ESGCT), 2023-present
- American Society for Virology (ASV), 2023-present
Honors and Awards
- Excellent Young Scholar funding recipient, Hunan Educational Department, China, 2014-2016
- Meritorious Abstract Travel Award, American Society of Gene & Cell Therapy, 2018
- Distinguished Postdoc Award in Gene Therapy, Pfizer, North Carolina Biotech, 2018
- Postdoc Travel Award, University of North Carolina, 2020
- Postdoc Award for Research Excellence, University of North Carolina, 2020
- Qais Farjo Memorial Grant, ARVO Foundation for Eye Research, 2021
- ASGCT Career Development Award, 2022